CTOs on the Move

OncoGenex

www.OncoGenex.com

 
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in ...
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Thriva

Thriva is a company that provides at-home blood tests to help individuals track and improve their health. They offer personalized blood tests, GP-reviewed results in 48 hours, and evidence-based advice.

Oerth Bio

At Oerth Bio™, we are on a mission to change perceptions of agricultural chemistry We are leading a new and transformative approach to crop protection, crop health and healthy food by leveraging our proprietary PROTAC® protein degraders, or proteolysis-targeting chimeras. PROTAC protein degraders work by harnessing the plant`s own natural protein disposal system to degrade and remove unwanted proteins. We are an early-stage agriculture biotechnology company located in the heart of downtown Durham, North Carolina.

Encore Research Group

Encore Research Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wright and Filippis

Wright and Filippis is a Rochester Hls, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

On Belay Health Solutions

On Belay Health Solutions is a company that supports independent primary care physicians in their quest to access meaningful value-based contracts and provides the clinical support necessary to succeed and maintain their independence.